Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study.
Portugal
Rodrigo
R
Schaffel
Rony
R
Almeida
Leandro
L
Spector
Nelson
N
Nucci
Marcio
M
D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006402:Hematologic Diseases / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D013322:Strongyloidiasis / Q000188:drug therapy / Q000517:prevention & control*; D013827:Thiabendazole / Q000627:therapeutic use*; D016896:Treatment Outcome
D013827:Thiabendazole